Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study

Local injections of platelet-rich plasma (PRP) and hyaluronic acid (HLA) are considered an effective method for treating chronic shoulder pain (CSP) associated with damage to the tendons of the rotator cuff muscles (RCM).The aim of the study is to compare the effectiveness and safety of local therap...

Full description

Bibliographic Details
Main Authors: V. A. Nesterenko, A. E. Karateev, M. A. Makarov, E. I. Byalik, S. A. Makarov, A. M. Lila
Format: Article
Language:Russian
Published: IMA PRESS LLC 2020-11-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2947
_version_ 1826555938244395008
author V. A. Nesterenko
A. E. Karateev
M. A. Makarov
E. I. Byalik
S. A. Makarov
A. M. Lila
author_facet V. A. Nesterenko
A. E. Karateev
M. A. Makarov
E. I. Byalik
S. A. Makarov
A. M. Lila
author_sort V. A. Nesterenko
collection DOAJ
description Local injections of platelet-rich plasma (PRP) and hyaluronic acid (HLA) are considered an effective method for treating chronic shoulder pain (CSP) associated with damage to the tendons of the rotator cuff muscles (RCM).The aim of the study is to compare the effectiveness and safety of local therapy of PRP and HLA in patients with CSP caused by damage to the tendons of the RCM muscles.Materials and methods. The study included 100 patients (54% women and 46% men, average age 51.5±15.1 years) with CSP (persisting for ≥3 months) associated with damage and tendinitis of the supraspinatus, subacute, scapular or small round muscle, confirmed by magnetic resonance imaging or ultrasound (ultrasound). The patients were randomized into two groups of 50 people who were treated with PRP (three injections at 7-day intervals) or HLA (two injections at 7-day intervals). The injections were performed under ultrasound control in the subacromial SAC. The results of the study were evaluated by the dynamics of pain intensity (on a visual analog scale, up to 100 mm) and functional disorders (ASES and CSS indices) after 1, 3 and 6 months.Results. Against the background of the use of PRP and HLA, there was a significant improvement in the condition of patients, while both drugs showed approximately the same effectiveness. The severity of VAS pain decreased from 56.8±15, respectively, after 6 months.5 and 57.6±17.8 mm to 31.8±27.8 and 30.2±26.3 mm, ASES-c 55.8±15.9 and 53.6±14.7 to 74.6±22.4 and 77.3± 22.4, CSS-c 59.2±14.4 and 47.8±16.9 to 69.9±17.3 and 65.6±19.2. the Dynamics of all these indicators in comparison with the baseline level was statistically significant (p<0.001). Number of patients with moderate / mild pain (<40 mm VAS) after 6 months. after the introduction of PRP and HLA was 48% and 60%, requiring regular NSAID intake 30% and 28%, respectively. In all parameters, the difference in the effectiveness of PRP and HLC was not statistically significant (p>0.05). The effectiveness of PRP and HLA (in terms of pain dynamics, ASES, and CSS) was significantly higher in individuals younger than 45 years, compared to older patients. The tolerability of therapy was good – after the introduction of PRP, 40% of patients had a short-term (3–4 days) increase in pain, which did not require the use of additional analgesics or interruption of treatment. No serious adverse reactions were observed when using PRP and HLA.Conclusion. OTP and GLA are effective and safe in the treatment of CSP associated with damage to the tendons of the RCM muscles. The dynamics of pain intensity and functional status after the use of these drugs did not differ. Treatment of PRP and HLA is more effective in people younger than 45 years.
first_indexed 2024-04-09T22:22:46Z
format Article
id doaj.art-5256c74187834ca4a51f0d8cbde14d63
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2025-03-14T08:04:45Z
publishDate 2020-11-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-5256c74187834ca4a51f0d8cbde14d632025-03-02T13:23:48ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922020-11-0158557057610.47360/1995-4484-2020-570-5762645Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical studyV. A. Nesterenko0A. E. Karateev1M. A. Makarov2E. I. Byalik3S. A. Makarov4A. M. Lila5V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyLocal injections of platelet-rich plasma (PRP) and hyaluronic acid (HLA) are considered an effective method for treating chronic shoulder pain (CSP) associated with damage to the tendons of the rotator cuff muscles (RCM).The aim of the study is to compare the effectiveness and safety of local therapy of PRP and HLA in patients with CSP caused by damage to the tendons of the RCM muscles.Materials and methods. The study included 100 patients (54% women and 46% men, average age 51.5±15.1 years) with CSP (persisting for ≥3 months) associated with damage and tendinitis of the supraspinatus, subacute, scapular or small round muscle, confirmed by magnetic resonance imaging or ultrasound (ultrasound). The patients were randomized into two groups of 50 people who were treated with PRP (three injections at 7-day intervals) or HLA (two injections at 7-day intervals). The injections were performed under ultrasound control in the subacromial SAC. The results of the study were evaluated by the dynamics of pain intensity (on a visual analog scale, up to 100 mm) and functional disorders (ASES and CSS indices) after 1, 3 and 6 months.Results. Against the background of the use of PRP and HLA, there was a significant improvement in the condition of patients, while both drugs showed approximately the same effectiveness. The severity of VAS pain decreased from 56.8±15, respectively, after 6 months.5 and 57.6±17.8 mm to 31.8±27.8 and 30.2±26.3 mm, ASES-c 55.8±15.9 and 53.6±14.7 to 74.6±22.4 and 77.3± 22.4, CSS-c 59.2±14.4 and 47.8±16.9 to 69.9±17.3 and 65.6±19.2. the Dynamics of all these indicators in comparison with the baseline level was statistically significant (p<0.001). Number of patients with moderate / mild pain (<40 mm VAS) after 6 months. after the introduction of PRP and HLA was 48% and 60%, requiring regular NSAID intake 30% and 28%, respectively. In all parameters, the difference in the effectiveness of PRP and HLC was not statistically significant (p>0.05). The effectiveness of PRP and HLA (in terms of pain dynamics, ASES, and CSS) was significantly higher in individuals younger than 45 years, compared to older patients. The tolerability of therapy was good – after the introduction of PRP, 40% of patients had a short-term (3–4 days) increase in pain, which did not require the use of additional analgesics or interruption of treatment. No serious adverse reactions were observed when using PRP and HLA.Conclusion. OTP and GLA are effective and safe in the treatment of CSP associated with damage to the tendons of the RCM muscles. The dynamics of pain intensity and functional status after the use of these drugs did not differ. Treatment of PRP and HLA is more effective in people younger than 45 years.https://rsp.mediar-press.net/rsp/article/view/2947chronic shoulder painshoulder rotator compression syndromeplatelet-rich plasmahyaluronic acidsubacromial administrationefficacysafety
spellingShingle V. A. Nesterenko
A. E. Karateev
M. A. Makarov
E. I. Byalik
S. A. Makarov
A. M. Lila
Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study
Научно-практическая ревматология
chronic shoulder pain
shoulder rotator compression syndrome
platelet-rich plasma
hyaluronic acid
subacromial administration
efficacy
safety
title Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study
title_full Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study
title_fullStr Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study
title_full_unstemmed Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study
title_short Comparison of the effectiveness of subacromial administration of platelet-rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6-month open clinical study
title_sort comparison of the effectiveness of subacromial administration of platelet rich plasma and hyaluronic acid in chronic shoulder pain caused by damage to the tendons of the rotator cuff muscles according to a 6 month open clinical study
topic chronic shoulder pain
shoulder rotator compression syndrome
platelet-rich plasma
hyaluronic acid
subacromial administration
efficacy
safety
url https://rsp.mediar-press.net/rsp/article/view/2947
work_keys_str_mv AT vanesterenko comparisonoftheeffectivenessofsubacromialadministrationofplateletrichplasmaandhyaluronicacidinchronicshoulderpaincausedbydamagetothetendonsoftherotatorcuffmusclesaccordingtoa6monthopenclinicalstudy
AT aekarateev comparisonoftheeffectivenessofsubacromialadministrationofplateletrichplasmaandhyaluronicacidinchronicshoulderpaincausedbydamagetothetendonsoftherotatorcuffmusclesaccordingtoa6monthopenclinicalstudy
AT mamakarov comparisonoftheeffectivenessofsubacromialadministrationofplateletrichplasmaandhyaluronicacidinchronicshoulderpaincausedbydamagetothetendonsoftherotatorcuffmusclesaccordingtoa6monthopenclinicalstudy
AT eibyalik comparisonoftheeffectivenessofsubacromialadministrationofplateletrichplasmaandhyaluronicacidinchronicshoulderpaincausedbydamagetothetendonsoftherotatorcuffmusclesaccordingtoa6monthopenclinicalstudy
AT samakarov comparisonoftheeffectivenessofsubacromialadministrationofplateletrichplasmaandhyaluronicacidinchronicshoulderpaincausedbydamagetothetendonsoftherotatorcuffmusclesaccordingtoa6monthopenclinicalstudy
AT amlila comparisonoftheeffectivenessofsubacromialadministrationofplateletrichplasmaandhyaluronicacidinchronicshoulderpaincausedbydamagetothetendonsoftherotatorcuffmusclesaccordingtoa6monthopenclinicalstudy